Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Market Cap	45.41B
Revenue (ttm)	13.56B
Net Income (ttm)	1.61B
Shares Out	91.67M
EPS (ttm)	17.56
PE Ratio	28.21
Forward PE	23.46
Dividend	4.50 (0.91%)
Ex-Dividend Date	Sep 13, 2024

Volume	52,027
Average Volume	472,863
Open	495.00
Previous Close	495.35
Day's Range	492.05 - 499.40
52-Week Range	232.50 - 572.00
Beta	0.60
RSI	66.16
Earnings Date	Jul 31, 2025

About NSE:INDRAMEDCO

Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, ...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1983
• Employees: 2,977
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INDRAMEDCO

Financial Performance

In 2024, NSE:INDRAMEDCO's revenue was 13.56 billion, an increase of 8.97% compared to the previous year's 12.45 billion. Earnings were 1.61 billion, an increase of 29.87%.